Submission for OMB Review; Comment Request, 64128-64130 [2018-27041]
Download as PDF
<![CDATA[
64128
Federal Register / Vol. 83, No. 239 / Thursday, December 13, 2018 / Notices
DEPARTMENT OF DEFENSE
A. Purpose
GENERAL SERVICES
ADMINISTRATION
Per Federal Acquisition Regulation
Part 48, value engineering is the
technique by which contractors (1)
voluntarily suggest methods for
performing more economically and
share in any resulting savings, or (2) are
required to establish a program to
identify and submit to the Government
methods for performing more
economically. These recommendations
are submitted to the Government as
value engineering change proposals
(VECP’s) and they must include specific
information. This information is needed
to enable the Government to evaluate
the VECP and, if accepted, to arrange for
an equitable sharing plan.
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[OMB Control No. 9000–0027; Docket No.
2018–0003; Sequence No. 25]
Information Collection; Value
Engineering Requirements
Department of Defense (DOD),
General Services Administration (GSA),
and National Aeronautics and Space
Administration (NASA).
ACTION: Notice and request for
comments.
AGENCY:
Under the provisions of the
Paperwork Reduction Act and the Office
of Management and Budget (OMB)
regulations, the Federal Acquisition
Regulation (FAR) Council invites the
public to comment on a renewal of an
approved information collection
requirement concerning value
engineering requirements.
DATES: Submit comments on or before
February 11, 2019.
ADDRESSES: The FAR Council invites
interested persons to submit comments
on this information collection by any of
the following methods:
• Federal eRulemaking Portal: This
website provides the ability to type
short comments directly into the
comment field or attach a file for
lengthier comments. Go to https://
www.regulations.gov and follow the
instructions on the site.
• Mail: General Services
Administration, Regulatory Secretariat
Division (MVCB), 1800 F Street NW,
Washington, DC 20405. ATTN: Ms.
Mandell/IC 9000–0027, Value
Engineering Requirements.
Instructions: All items submitted
must cite ‘‘Information Collection 9000–
0027, Value Engineering Requirements.’’
Comments received generally will be
posted without change to https://
www.regulations.gov, including any
personal and/or business confidential
information provided. To confirm
receipt of your comment(s), please
check www.regulations.gov,
approximately two to three days after
submission to verify posting (except
allow 30 days for posting of comments
submitted by mail).
FOR FURTHER INFORMATION CONTACT: Ms.
Marilyn E. Chambers, Procurement
Analyst, 202–285–7380, or
marilyn.chambers@gsa.gov.
SUPPLEMENTARY INFORMATION:
amozie on DSK3GDR082PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:12 Dec 12, 2018
Jkt 247001
B. Annual Reporting Burden
Respondents: 794.
Responses per Respondent: 2.
Annual Responses: 1,588.
Hours per Response: 15.
Total Burden Hours: 23,820.
Affected Public: Business or other forprofit entities.
Reporting Frequency: On occasion.
C. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary; whether it will
have practical utility; whether our
estimate of the public burden of this
collection of information is accurate,
and based on valid assumptions and
methodology; ways to enhance the
quality, utility, and clarity of the
information to be collected; and ways in
which we can minimize the burden of
the collection of information on those
who are to respond, through the use of
appropriate technological collection
techniques or other forms of information
technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW, Washington, DC
20405, telephone 202–501–4755.
Please cite OMB Control No. 9000–
0027, Value Engineering Requirements,
in all correspondence.
Dated: December 10, 2018.
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
[FR Doc. 2018–27019 Filed 12–12–18; 8:45 am]
BILLING CODE 6820–EP–P
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Regional Partnership Grant
National Cross-Site Evaluation and
Evaluation Technical Assistance.
OMB No.: 0970–NEW.
Description: The Children’s Bureau
(CB) within the Administration for
Children and Families of the U.S.
Department of Health and Human
Services seeks approval to collect
information for the Regional Partnership
Grants to Increase the Well-being of and
to Improve Permanency Outcomes for
Children Affected by Substance Abuse
(known as the Regional Partnership
Grants Program or ‘‘RPG’’) Cross-Site
Evaluation and Evaluation-Related
Technical Assistance project. The Child
and Family Services Improvement and
Innovation Act (Pub. L. 112–34)
includes a targeted grants program
(section 437(f) of the Social Security
Act) that directs the Secretary of Health
and Human Services to reserve a
specified portion of the appropriation
for these Regional Partnership Grants, to
be used to improve the well-being of
children affected by substance abuse.
Under three prior rounds of RPG, the
Children’s Bureau has issued 74 grants
to organizations such as child welfare or
substance abuse treatment providers or
family court systems to develop
interagency collaborations and
integration of programs, activities, and
services designed to increase well-being,
improve permanency, and enhance the
safety of children who are in an out-ofhome placement or are at risk of being
placed in out-of-home care as a result of
a parent’s or caretaker’s substance
abuse. In 2017, CB awarded grants to a
fourth cohort of 17 grantees and in 2018
they plan to award 10 grants to a fifth
cohort.
The RPG cross-site evaluation will
extend our understanding of what types
of programs and services grantees
provided to participants, how grantees
leveraged their partnerships to
coordinate services for children and
families, and what the outcomes were
for children and families enrolled in
RPG programs. First, the cross-site
evaluation will describe the
characteristics of participants served by
RPG programs, the types of services
provided to families, the dosage of each
type of service received by families, and
the level of participant engagement with
the services provided. Second, the
E:\FR\FM\13DEN1.SGM
13DEN1
64129
Federal Register / Vol. 83, No. 239 / Thursday, December 13, 2018 / Notices
cross-site will assess the coordination of
partners’ service systems (e.g., shared
participant data, joint staff training) to
better understand how partners’
collaborative effort affects the array of
services offered to families. The crosssite evaluation will also focus more
deeply on the partnership between the
child welfare and substance use
disorder (SUD) treatment agencies, to
add to the research base about how
these agencies can collaborate to
address the needs of children and
families affected by SUD. Finally, the
evaluation will assess the outcomes of
children and adults served through the
RPG program.
The evaluation is being undertaken by
the Children’s Bureau and its contractor
Mathematica Policy Research. The
evaluation is being implemented by
Mathematica Policy Research and its
subcontractor, WRMA Inc.
The RPG Cross-Site Evaluation will
include the following data collection
activities:
1. Site visits and key informant
interviews. The cross-site evaluation
team will visit up to 21 sites to better
understand the partnership and
coordination between the child welfare
and SUD treatment agencies. The
remaining six grantees will participate
in telephone interviews to gather similar
information about their design and
implementation. The site visits and
phone interviews will focus on the RPG
planning process; how and why
particular services were selected; the
ability of the child welfare, substance
use disorder treatment, and other
service systems to collaborate and
support quality implementation of the
RPG services; challenges experienced;
and the potential for sustaining the
collaborations and services after RPG
funding ends.
2. Partner survey. To describe the
interagency collaboration within RPG
sites, grantees and their partners will
participate in an online survey once
during the grant period. One person
from each organization knowledgeable
about the RPG program will be invited
to participate in the survey. The survey
will collect information about
communication and service
coordination among partners. The
survey will also collect information on
characteristics of strong partnerships
(e.g., data sharing agreements,
colocation of staff, referral procedures,
and cross-staff training).
3. Semi-annual progress reports. The
semi-annual progress reports will be
used to obtain updated information
from grantee project directors about
their program operations and
partnerships, including any changes
from prior periods. The CB has tailored
the semi-annual progress reports to
collect information on grantees’
programs and other services grantees
implement, the target population for the
RPG program, and grantees’ perceived
successes and challenges to
implementation.
4. Enrollment, client, and service
data. To document participant
characteristics and their enrollment in
RPG services, all grantees will provide
data on family characteristics, and
enrollment of and services provided to
RPG families. These data include
demographic information on family
members, dates of entry into and exit
from RPG services, and information on
RPG service dosage. These data will be
submitted on an ongoing basis by staff
at the grantee organizations into an
information system developed by the
cross-site evaluation team.
5. Outcome and impact data. To
measure participant outcomes, all
grantees will collect self-administered
standardized instruments from RPG
adults. The standardized instruments
used in RPG collect information on
child well-being, adult and family
functioning, and adult substance use.
Grantees will share the responses on
these self-report instruments with the
cross-site evaluation team. Grantees will
also obtain administrative data on a
common set of child welfare and
substance use disorder treatment data
elements.
In addition to conducting local
evaluations and participating in the RPG
Cross-Site Evaluation, the RPG grantees
are legislatively required to report
performance indicators aligned with
their proposed program strategies and
activities. A key strategy of the RPG
Cross-Site Evaluation is to minimize
burden on the grantees by ensuring that
the cross-site evaluation, which
includes all grantees in a study that
collects data to report on
implementation, the partnerships, and
participant characteristics and
outcomes, fully meets the need for
performance reporting. Thus, rather
than collecting separate evaluation and
performance indicator data, the grantees
need only participate in the cross-site
evaluation. In addition, using the
standardized instruments that the
Children’s Bureau has specified will
ensure that grantees have valid and
reliable data on child and family
outcomes for their local evaluations.
The inclusion of an impact study
conducted on a subset of grantees with
rigorous designs will also provide the
Children’s Bureau, Congress, grantees,
providers, and researchers with
information about the effectiveness of
RPG programs.
A 60-Day Federal Register Notice was
published for this study on October 10,
2018. This 30-Day Federal Register
Notice covers the following data
collection activities: (1) The site visits
with grantees; (2) the web-based survey
of grantee partners (3) the semi-annual
progress reports; (4) enrollment and
service data provided by grantees; and
(6) outcome and impact data provided
by grantees.
Respondents. Respondents include
grantee staff or contractors (such as local
evaluators) and partner staff. Specific
types of respondents and the expected
number per data collection effort are
noted in the burden table below.
Annual burden estimates. The
following instruments are proposed for
public comment under this 30-Day
Federal Register Notice. Burden for all
components is annualized over three
years.
RPG CROSS-SITE EVALUATION ANNUALIZED BURDEN ESTIMATES
Total number
of respondents
amozie on DSK3GDR082PROD with NOTICES1
Data collection activity
Number of
responses per
respondent
(each year)
Average
burden hours
per response
(in hours)
Estimated total
burden hours
Total annual
burden hours
Site Visit and Key Informant Data Collection
Program director in-person interview ...................................
Program manager/supervisor in-person interview ...............
Partner representative interviews ........................................
Frontline staff interview ........................................................
Program director/manager phone interview ........................
VerDate Sep<11>2014
17:12 Dec 12, 2018
Jkt 247001
PO 00000
Frm 00033
21
21
63
42
12
Fmt 4703
Sfmt 4703
.33
.33
.33
.33
.33
E:\FR\FM\13DEN1.SGM
2
1
1
1
1
13DEN1
42
21
63
42
4.0
14
7
21
14
12
64130
Federal Register / Vol. 83, No. 239 / Thursday, December 13, 2018 / Notices
RPG CROSS-SITE EVALUATION ANNUALIZED BURDEN ESTIMATES—Continued
Data collection activity
Total number
of respondents
Number of
responses per
respondent
(each year)
135
.33
Partner survey ......................................................................
Average
burden hours
per response
(in hours)
Estimated total
burden hours
Total annual
burden hours
0.42
56.3
18.8
2
43
43
33
2,288
16.5
0.25
0.017
0.017
0.03
2,673
2,612.3
174.2
133.7
37,065
891
870.8
58.1
44.6
12,355
27
27
1
2
42.6
144
3,450.6
23,328
1150.2
7,776
27
27
27
22
.33
130
2
130
8
1.25
25
1.25
216
13,162.5
4,050
10,725
72
4,387.5
1,350
3,575
........................
........................
........................
97,827
32,609
Enrollment, client and service data
Semi-annual progress reports .............................................
Case enrollment data ...........................................................
Case closure ........................................................................
Case closure—prenatal .......................................................
Service log entries ...............................................................
27
81
81
81
162
Outcome and impact data
Administrative Data:
Obtain access to administrative data ...........................
Report administrative data ............................................
Standardized instruments:
Review and adopt reporting templates .........................
Data entry for standardized instruments ......................
Review records and submit ..........................................
Data entry for comparison study sites (22 grantees) ...
Estimated Total Burden Hours .....................................
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 330
C Street SW, Washington, DC 20201.
Attention Reports Clearance Officer. All
requests should be identified by the title
of the information collection. Email
address: infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2018–27041 Filed 12–12–18; 8:45 am]
amozie on DSK3GDR082PROD with NOTICES1
BILLING CODE 4184–01–P
VerDate Sep<11>2014
17:12 Dec 12, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–P–1734]
Determination That IC–GREEN
(Indocyanine Green for Injection), 10
Milligrams/Vial, 40 Milligrams/Vial, and
50 Milligrams/Vial Were Not Withdrawn
From Sale for Reasons of Safety or
Effectiveness
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) has
determined that IC–GREEN
(indocyanine green for injection), 10
milligrams (mg)/vial, 40 mg/vial, and 50
mg/vial, was not withdrawn from sale
for reasons of safety or effectiveness.
This determination will allow FDA to
approve abbreviated new drug
applications (ANDAs) for indocyanine
green for injection, 10 mg/vial, 40 mg/
vial, and 50 mg/vial if all other legal and
regulatory requirements are met.
FOR FURTHER INFORMATION CONTACT:
Heather A. Dorsey, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6219,
Silver Spring, MD 20993–0002, 301–
796–3601.
SUPPLEMENTARY INFORMATION: In 1984,
Congress enacted the Drug Price
Competition and Patent Term
SUMMARY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Restoration Act of 1984 (Pub. L. 98–417)
(the 1984 amendments), which
authorized the approval of duplicate
versions of drug products under an
ANDA procedure. ANDA applicants
must, with certain exceptions, show that
the drug for which they are seeking
approval contains the same active
ingredient in the same strength and
dosage form as the ‘‘listed drug,’’ which
is a version of the drug that was
previously approved. ANDA applicants
do not have to repeat the extensive
clinical testing otherwise necessary to
gain approval of a new drug application
(NDA).
The 1984 amendments include what
is now section 505(j)(7) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C.
355(j)(7)), which requires FDA to
publish a list of all approved drugs.
FDA publishes this list as part of the
‘‘Approved Drug Products with
Therapeutic Equivalence Evaluations,’’
which is known generally as the
‘‘Orange Book.’’ Under FDA regulations,
drugs are removed from the list if the
Agency withdraws or suspends
approval of the drug’s NDA or ANDA
for reasons of safety or effectiveness or
if FDA determines that the listed drug
was withdrawn from sale for reasons of
safety or effectiveness (21 CFR 314.162).
A person may petition the Agency to
determine, or the Agency may
determine on its own initiative, whether
a listed drug was withdrawn from sale
for reasons of safety or effectiveness.
This determination may be made at any
time after the drug has been withdrawn
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 83, Number 239 (Thursday, December 13, 2018)]
[Notices]
[Pages 64128-64130]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27041]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: Regional Partnership Grant National Cross-Site Evaluation
and Evaluation Technical Assistance.
OMB No.: 0970-NEW.
Description: The Children's Bureau (CB) within the Administration
for Children and Families of the U.S. Department of Health and Human
Services seeks approval to collect information for the Regional
Partnership Grants to Increase the Well-being of and to Improve
Permanency Outcomes for Children Affected by Substance Abuse (known as
the Regional Partnership Grants Program or ``RPG'') Cross-Site
Evaluation and Evaluation-Related Technical Assistance project. The
Child and Family Services Improvement and Innovation Act (Pub. L. 112-
34) includes a targeted grants program (section 437(f) of the Social
Security Act) that directs the Secretary of Health and Human Services
to reserve a specified portion of the appropriation for these Regional
Partnership Grants, to be used to improve the well-being of children
affected by substance abuse. Under three prior rounds of RPG, the
Children's Bureau has issued 74 grants to organizations such as child
welfare or substance abuse treatment providers or family court systems
to develop interagency collaborations and integration of programs,
activities, and services designed to increase well-being, improve
permanency, and enhance the safety of children who are in an out-of-
home placement or are at risk of being placed in out-of-home care as a
result of a parent's or caretaker's substance abuse. In 2017, CB
awarded grants to a fourth cohort of 17 grantees and in 2018 they plan
to award 10 grants to a fifth cohort.
The RPG cross-site evaluation will extend our understanding of what
types of programs and services grantees provided to participants, how
grantees leveraged their partnerships to coordinate services for
children and families, and what the outcomes were for children and
families enrolled in RPG programs. First, the cross-site evaluation
will describe the characteristics of participants served by RPG
programs, the types of services provided to families, the dosage of
each type of service received by families, and the level of participant
engagement with the services provided. Second, the
[[Page 64129]]
cross-site will assess the coordination of partners' service systems
(e.g., shared participant data, joint staff training) to better
understand how partners' collaborative effort affects the array of
services offered to families. The cross-site evaluation will also focus
more deeply on the partnership between the child welfare and substance
use disorder (SUD) treatment agencies, to add to the research base
about how these agencies can collaborate to address the needs of
children and families affected by SUD. Finally, the evaluation will
assess the outcomes of children and adults served through the RPG
program.
The evaluation is being undertaken by the Children's Bureau and its
contractor Mathematica Policy Research. The evaluation is being
implemented by Mathematica Policy Research and its subcontractor, WRMA
Inc.
The RPG Cross-Site Evaluation will include the following data
collection activities:
1. Site visits and key informant interviews. The cross-site
evaluation team will visit up to 21 sites to better understand the
partnership and coordination between the child welfare and SUD
treatment agencies. The remaining six grantees will participate in
telephone interviews to gather similar information about their design
and implementation. The site visits and phone interviews will focus on
the RPG planning process; how and why particular services were
selected; the ability of the child welfare, substance use disorder
treatment, and other service systems to collaborate and support quality
implementation of the RPG services; challenges experienced; and the
potential for sustaining the collaborations and services after RPG
funding ends.
2. Partner survey. To describe the interagency collaboration within
RPG sites, grantees and their partners will participate in an online
survey once during the grant period. One person from each organization
knowledgeable about the RPG program will be invited to participate in
the survey. The survey will collect information about communication and
service coordination among partners. The survey will also collect
information on characteristics of strong partnerships (e.g., data
sharing agreements, colocation of staff, referral procedures, and
cross-staff training).
3. Semi-annual progress reports. The semi-annual progress reports
will be used to obtain updated information from grantee project
directors about their program operations and partnerships, including
any changes from prior periods. The CB has tailored the semi-annual
progress reports to collect information on grantees' programs and other
services grantees implement, the target population for the RPG program,
and grantees' perceived successes and challenges to implementation.
4. Enrollment, client, and service data. To document participant
characteristics and their enrollment in RPG services, all grantees will
provide data on family characteristics, and enrollment of and services
provided to RPG families. These data include demographic information on
family members, dates of entry into and exit from RPG services, and
information on RPG service dosage. These data will be submitted on an
ongoing basis by staff at the grantee organizations into an information
system developed by the cross-site evaluation team.
5. Outcome and impact data. To measure participant outcomes, all
grantees will collect self-administered standardized instruments from
RPG adults. The standardized instruments used in RPG collect
information on child well-being, adult and family functioning, and
adult substance use. Grantees will share the responses on these self-
report instruments with the cross-site evaluation team. Grantees will
also obtain administrative data on a common set of child welfare and
substance use disorder treatment data elements.
In addition to conducting local evaluations and participating in
the RPG Cross-Site Evaluation, the RPG grantees are legislatively
required to report performance indicators aligned with their proposed
program strategies and activities. A key strategy of the RPG Cross-Site
Evaluation is to minimize burden on the grantees by ensuring that the
cross-site evaluation, which includes all grantees in a study that
collects data to report on implementation, the partnerships, and
participant characteristics and outcomes, fully meets the need for
performance reporting. Thus, rather than collecting separate evaluation
and performance indicator data, the grantees need only participate in
the cross-site evaluation. In addition, using the standardized
instruments that the Children's Bureau has specified will ensure that
grantees have valid and reliable data on child and family outcomes for
their local evaluations. The inclusion of an impact study conducted on
a subset of grantees with rigorous designs will also provide the
Children's Bureau, Congress, grantees, providers, and researchers with
information about the effectiveness of RPG programs.
A 60-Day Federal Register Notice was published for this study on
October 10, 2018. This 30-Day Federal Register Notice covers the
following data collection activities: (1) The site visits with
grantees; (2) the web-based survey of grantee partners (3) the semi-
annual progress reports; (4) enrollment and service data provided by
grantees; and (6) outcome and impact data provided by grantees.
Respondents. Respondents include grantee staff or contractors (such
as local evaluators) and partner staff. Specific types of respondents
and the expected number per data collection effort are noted in the
burden table below.
Annual burden estimates. The following instruments are proposed for
public comment under this 30-Day Federal Register Notice. Burden for
all components is annualized over three years.
RPG Cross-Site Evaluation Annualized Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Total number responses per hours per Estimated Total annual
Data collection activity of respondents respondent response (in total burden burden hours
(each year) hours) hours
----------------------------------------------------------------------------------------------------------------
Site Visit and Key Informant Data Collection
----------------------------------------------------------------------------------------------------------------
Program director in-person 21 .33 2 42 14
interview......................
Program manager/supervisor in- 21 .33 1 21 7
person interview...............
Partner representative 63 .33 1 63 21
interviews.....................
Frontline staff interview....... 42 .33 1 42 14
Program director/manager phone 12 .33 1 4.0 12
interview......................
[[Page 64130]]
Partner survey.................. 135 .33 0.42 56.3 18.8
----------------------------------------------------------------------------------------------------------------
Enrollment, client and service data
----------------------------------------------------------------------------------------------------------------
Semi-annual progress reports.... 27 2 16.5 2,673 891
Case enrollment data............ 81 43 0.25 2,612.3 870.8
Case closure.................... 81 43 0.017 174.2 58.1
Case closure--prenatal.......... 81 33 0.017 133.7 44.6
Service log entries............. 162 2,288 0.03 37,065 12,355
----------------------------------------------------------------------------------------------------------------
Outcome and impact data
----------------------------------------------------------------------------------------------------------------
Administrative Data:
Obtain access to 27 1 42.6 3,450.6 1150.2
administrative data........
Report administrative data.. 27 2 144 23,328 7,776
Standardized instruments:
Review and adopt reporting 27 .33 8 216 72
templates..................
Data entry for standardized 27 130 1.25 13,162.5 4,387.5
instruments................
Review records and submit... 27 2 25 4,050 1,350
Data entry for comparison 22 130 1.25 10,725 3,575
study sites (22 grantees)..
-------------------------------------------------------------------------------
Estimated Total Burden Hours .............. .............. .............. 97,827 32,609
----------------------------------------------------------------------------------------------------------------
Additional Information: Copies of the proposed collection may be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research and Evaluation, 330 C Street SW,
Washington, DC 20201. Attention Reports Clearance Officer. All requests
should be identified by the title of the information collection. Email
address: [email protected].
OMB Comment: OMB is required to make a decision concerning the
collection of information between 30 and 60 days after publication of
this document in the Federal Register. Therefore, a comment is best
assured of having its full effect if OMB receives it within 30 days of
publication. Written comments and recommendations for the proposed
information collection should be sent directly to the following: Office
of Management and Budget, Paperwork Reduction Project, Email:
[email protected], Attn: Desk Officer for the Administration
for Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2018-27041 Filed 12-12-18; 8:45 am]
BILLING CODE 4184-01-P
